Authors:
LASSFLORL C
KOFLER G
KROPSHOFER G
HERMANS J
KRECZY A
DIERICH MP
NIEDERWIESER D
Citation: C. Lassflorl et al., IN-VITRO TESTING OF SUSCEPTIBILITY TO AMPHOTERICIN-B IS A RELIABLE PREDICTOR OF CLINICAL OUTCOME IN INVASIVE ASPERGILLOSIS, Journal of antimicrobial chemotherapy, 42(4), 1998, pp. 497-502
Authors:
NACHBAUR D
FINK FM
NUSSBAUMER W
GACHTER A
KROPSHOFER G
LUDESCHER C
NIEDERWIESER D
Citation: D. Nachbaur et al., CD34(-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN PATIENTS WITH POOR-RISK HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS - A SINGLE-CENTER EXPERIENCE()), Bone marrow transplantation, 20(10), 1997, pp. 827-834
Authors:
NACHBAUR D
DUBA HC
FEICHTINGER H
KROPSHOFER G
NUSSBAUMER W
SCHWAIGHOFER H
NIEDERWIESER D
Citation: D. Nachbaur et al., POLYCHEMOTHERAPY COMBINED WITH G-CSF-MOBILIZED DONOR BUFFY COAT TRANSFUSION FOR GRANULOCYTIC SARCOMA AFTER ALLOGENEIC BMT FOR AML, Bone marrow transplantation, 19(9), 1997, pp. 947-949
Authors:
NACHBAUR D
KROPSHOFER G
FEICHTINGER H
ALLERBERGER F
NIEDERWIESER D
Citation: D. Nachbaur et al., CRYPTOSPORIDIOSIS AFTER CD34-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) - TREATMENT WITH PAROMOMYCIN, AZITHROMYCIN AND RECOMBINANT HUMAN INTERLEUKIN-2, Bone marrow transplantation, 19(12), 1997, pp. 1261-1263
Authors:
SCHWAIGHOFER H
OBERHUBER G
HEBART H
EINSELE H
HEROLD M
NACHBAUR D
EIBL B
TILG H
KROPSHOFER G
FERRARA JLM
NIEDERWIESER D
Citation: H. Schwaighofer et al., ENDOGENOUS INTERLEUKIN-1 RECEPTOR ANTAGONIST DURING HUMAN BONE-MARROWTRANSPLANTATION - INCREASED LEVELS DURING GRAFT-VERSUS-HOST DISEASE, DURING INFECTIOUS COMPLICATIONS, AND AFTER IMMUNOGLOBULIN THERAPY, Transplantation, 63(1), 1997, pp. 52-56